Upload
vukien
View
219
Download
3
Embed Size (px)
Citation preview
Biotechnology industry:
future needs and trends
Roland Wohlgemuth
Overview
Introduction
Innovation
Outlook and Opportunities
Introduction
European Federation of Biotechnology (EFB)
http://www.efb-central.org
European Federation of Biotechnology (EFB)
History
Established by European scientists in 1978, the European Federation of Biotechnology (EFB) is working to promote biotechnology throughout Europe and beyond.
http://www.efb-central.org
European Federation of Biotechnology (EFB)
Mission
The mission of EFB is to promote the safe, sustainable and beneficial use of the life sciences, to promote research and innovation at the cutting edge of biotechnology, to provide a forum for interdisciplinary and international cooperation, to improve scientific education and to facilitate an informed dialogue between scientists and the public.
http://www.efb-central.org
European Federation of Biotechnology (EFB)
http://www.efb-central.org
Members and Organization
With 108 Institutional members from across Europe and 13.500 personal members, the EFB has 14 Regional Branch Offices in Europe.The EFB Central Office (ECO) is located in Barcelona, Spain. Membership administration, organization of Executive Board meetings and General Assemblies, website management and organization of the European Congresses on Biotechnology are some of the main responsibilities of ECO.
The European Association for BioindustriesHistory and Organisation
The European Association for Bioindustries (EuropaBio) was created in 1996 to provide a voice for the biotech industry in Europe. The three main segments of biotech-nology are represented through sectoral councils: Healthcare (Red Biotech), Industrial (White Biotech) and Agri-Food (Green Biotech).The corporate members are involved in human and animal healthcare, diagnostics, bioinformatics, chemicals, crop protection, agriculture, food and environmental products and services. The board of management is made up of representatives of member companies and is supported by the secretariat. http://www.europabio.org
The European Association for BioindustriesMembers
EuropaBio has 62 corporate and 7 associate members operating worldwide, 2 Bioregions and 19 national biotechno-logy associations representing some 1800 small and medium sized enterprises.
http://www.europabio.org
Creating Value for the Customer, Coworker/Co-owner and Citizen
Goal: Focus on optimizing customer satisfaction while setting minimum boundary conditions for the other variables
Tools: Raw Materials - Science/Technology -Product Development - Manufacturing -Service - Supply Chain - Sales/Marketing
Creating Value for the Customer, Coworker/Co-owner and Citizen
Sustainable Value Creation well-balanced and anchored in Science-Industry-SocietyConcept of a more sustainable use of limited resources as a driving force for the rapid develop-ment of sustainable bioeconomies in US - EUValue creation by the conversion of abundant and inexpensive raw material into higher value products
Innovation
Global Challenges
R.Wohlgemuth, New Biotechnology 25, 204-219 (2009)
Ressource Efficiency
Product
Raw Material
Intermediate
Intermediate
R.Wohlgemuth, Chem. Biochem. Eng. Q. 25 (1) 125–134 (2011)
Ressource Efficiency
Waste Minimization by Molecular Economy
High Step Economy by Reducing the Number of Steps and Direct Transformations instead of Protection-Trans-formation-Deprotection SequencesSelective Transformations with High Atom EconomyRedox EconomyProduct Isolations & Purifications with Minimization of Auxiliary Reagents and SolventsWaste as Raw Material for New Processes
R.Wohlgemuth, Chem. Biochem. Eng. Q. 25 (1) 125–134 (2011)
•
Atmospheric Carbon dioxide - Past and Present
C.D.Keeling et al, Nature 375, 666-670 (1995)
P.N.Pearson, M.R.Palmer, Nature 406, 695-699 (2000)
Science/Technology
Precompetitive Fundamental Research on Novel Industrial Biotechnology Platform Technologies , e.g. Carbondioxide-Utilization Reactions with a Time Horizon of 10 Years and improving Ressource Efficiency
Capacity Building for the molecular sciences of syn-thesis (chemistry and biotechnology), bioproduction and engineering of new reagents, drugs and mate-rials towards Personalized Medicine
Precompetitive Fundamental Research on Novel Bioanalytical Platform Technologies
Science/Technology
R.Wohlgemuth, New Biotechnol. 25, 204-213 (2009)
Going beyond the present Functional Universe of Enzymes
Guidelines for Reporting of Biocatalytic Reactions
Global standards
Functional Database L.Gardossi, P.Poulsen, A.Ballesteros, K.Hult, V.Svedas, D.Vasic-Racki, G.Carrea, A.Magnusson, A.Schmid, R.Wohlgemuth, P.Halling, Trends in Biotechnol. 28, 171-180 (2010).
Science/Technology
Value creation by integrated biopro-cesses: Molecular and engineering aspects of the overall bioprocess are interconnected
Science/Technology
R.Wohlgemuth, Chem. Biochem. Eng. Q. 25 (1) 125–134 (2011)
Outlook and Opportunities
Sustainable Bioeconomy
With the Common Understanding and Agreement that this is the Way Forward,bioeconomy - subfields of mutual interest to the US and EU can be defined
Establishing Information Exchange US-EU in these bioeconomy-subfields
US-EU Exchange Program of Scientists in these defined bioeconomy – subfields
Sustainable Bioeconomy
The Time of Action is now and extensive efforts are needed for the transition of the US- and EU-economies to a sustai-nable bioeconomy
Building New Value Creation Chains
Focus on Generally Recognized As Safe Biological Cells
Sustainable Bioeconomy –Moving towards the Whole Molecular System of Cells
R.Wohlgemuth, Biotechnol.J. 9, 1253-1265 (2009).
Thank You for
Your Attention !
Roland Wohlgemuth